Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals Ownership Summary

Acurx Pharmaceuticals is owned by 10.96% institutional investors, 8.12% insiders, and 80.92% retail investors. Armistice capital is the largest institutional shareholder, holding 4.53% of ACXP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.97% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Acurx Pharmaceuticals	10.96%	8.12%	80.92%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	1.08M	4.53%	$550.92K
Vanguard group	529.35K	3.23%	$430.89K
Prospect financial services	296.78K	1.25%	$151.59K
Geode capital management	146.50K	0.90%	$119.27K
Sabby management	81.89K	0.34%	$41.83K
Morgan stanley	46.40K	0.30%	$104.40K
Susquehanna group, llp	48.37K	0.30%	$39.38K
State street	43.47K	0.27%	$35.38K
Vanguard capital wealth advisors	46.00K	0.19%	$23.50K
Blackrock	27.50K	0.18%	$61.88K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prospect financial services	296.78K	0.09%	$151.59K
Sabby management	81.89K	0.08%	$41.83K
Vanguard capital wealth advisors	46.00K	0.02%	$23.50K
Armistice capital	1.08M	0.01%	$550.92K
Semmax financial advisors	5.88K	0.00%	$11.17K
Gps wealth strategies group	23.50K	0.00%	$12.00K
Nbc securities	30.00K	0.00%	$15.00
Xtx topco	37.69K	0.00%	$19.25K
Tower research capital llc (trc)	4.45K	0.00%	$3.62K
Advisor group	14.18K	0.00%	$25.93K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	1.08M	0.01%	1.08M
Susquehanna group, llp	48.37K	-	48.37K
Xtx topco	37.69K	0.00%	37.69K
Gps wealth strategies group	23.50K	0.00%	23.00K
Morgan stanley	46.40K	-	20.00K

Top Sellers

Holder	Shares	% Assets	Change
Sabby management	81.89K	0.08%	-1.96M
Prospect financial services	296.78K	0.09%	-69.80K
Act advisors, llc.	-	-	-45.95K
Lpl financial	-	-	-44.78K
Blackrock funding, inc. /de	1.20K	-	-33.04K

New Positions

Holder	Shares	% Assets	Change	Value
Armistice capital	1.08M	0.01%	1.08M	$550.92K
Susquehanna group, llp	48.37K	-	48.37K	$39.38K
Xtx topco	37.69K	0.00%	37.69K	$19.25K
Renaissance	14.67K	-	14.67K	$11.95K

Sold Out

Holder	Change
Jpmorgan chase	-29.00
Wells fargo & company/mn	-87.00
Simplex trading	-1.16K
Northwestern mutual wealth management	-1.64K
Cornerstone planning group	-3.34K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	33	50.00%	2,610,048	79.65%	10	20.86%	19	90.00%	7	40.00%
Mar 31, 2025	23	-17.86%	3,497,399	146.63%	17	23.24%	11	-21.43%	5	25.00%
Dec 31, 2024	27	17.39%	1,410,919	13.03%	8	14.82%	13	116.67%	4	-33.33%
Sep 30, 2024	23	-11.54%	1,248,314	3.50%	7	12.55%	6	-45.45%	6	50.00%
Jun 30, 2024	26	-3.70%	1,206,131	-3.41%	7	8.03%	11	-35.29%	4	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	384.36K	1.97%	551.00
Vanguard Total Stock Mkt Idx Inv	383.81K	1.63%	-
Vanguard Institutional Extnd Mkt Idx Tr	141.52K	0.46%	-4.02K
Fidelity Extended Market Index	95.74K	0.30%	-674.00
iShares Micro-Cap ETF	27.76K	0.12%	-
Spartan Extended Market Index Pool E	15.76K	0.08%	650.00
NT Ext Equity Mkt Idx Fd - L	18.93K	0.08%	-
Northern Trust Extended Eq Market Idx	18.93K	0.06%	-
Fidelity Total Market Index	20.03K	0.06%	-
Fidelity Series Total Market Index	19.87K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 06, 2025	Scodari Joseph C	-	Buy	$25.00K
Jan 06, 2025	Scodari Joseph C	-	Buy	$22.17K
Jan 06, 2025	Sailer Carl	-	Buy	$25.00K
Jan 06, 2025	Sailer Carl	-	Buy	$22.17K
Jan 06, 2025	LUCI DAVID P	President and CEO	Buy	$50.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	12	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q2	-	-

ACXP Ownership FAQ

Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 10.96%, followed by 8.12% insiders and 80.92% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Armistice capital (1.08M shares, 4.53%), Vanguard group (529.35K shares, 3.23%), and Prospect financial services (296.78K shares, 1.25%). Together, they hold 9.01% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 296.78K Acurx Pharmaceuticals shares, valued at 151.59K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Acurx Pharmaceuticals shares, with 1.97% of its total shares outstanding invested in 384.36K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools